Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IFT57 pseudogene 1 (IFT57P1) is a pseudogene, meaning it is a genomic DNA sequence similar to a functional gene but generally nonfunctional; it does not encode an active protein and is not considered a therapeutic or biological target. Its name derives from sequence similarity to the genuine IFT57 protein-coding gene, which is involved in cilia and flagella formation as part of the intraflagellar transport complex, but IFT57P1 itself is not known to have any physiological or pathological function[3][6]. Key clarification: IFT57P1 is a pseudogene and not a therapeutic target, receptor, enzyme, or otherwise functionally relevant protein. If you are seeking information about the functional protein relevant in cilia biology, refer to "Intraflagellar transport protein 57" (IFT57), not IFT57P1. All known biological interactions, disease relevance, and molecular characterizations pertain to IFT57, not to the pseudogene IFT57P1[3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IFT57 pseudogene 1 (IFT57P1).